Class action lawsuits
Purchasers of KinderCare Learning Companies, Inc. (NYSE: KLC) common stock may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. A class action lawsuit has been filed, and the lead plaintiff deadline is October 14, 2025. The lawsuit claims that the registration
Class action lawsuits
The Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between May 7, 2025, and July 28, 2025, of the important September 30, 2025, lead plaintiff deadline in the ongoing class action lawsuit. The lawsuit alleges that Novo Nordisk
Class action lawsuits
According to a notice from the Gross Law Firm, shareholders of Novo Nordisk A/S (NYSE: NVO) who purchased shares during the class period of May 7, 2025, to July 28, 2025, are encouraged to contact the firm regarding possible lead plaintiff appointment. The firm alleges that defendants provided false
Class action lawsuits
Investors who purchased securities of Altimmune, Inc. between August 10, 2023, and June 25, 2025, may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. A class action lawsuit has already been filed, and the lead plaintiff deadline is October 6, 2025.
Class action lawsuits
Levi & Korsinsky, LLP has issued a notification to investors in Lineage, Inc. regarding a class action securities lawsuit seeking to recover losses allegedly caused by securities fraud. The lawsuit affects all buyers of Lineage common stock in or traceable to the registration statement used for the Company's
Class action lawsuits
Shareholders who purchased shares of Fiserv, Inc. (NYSE: FI) during the class period from July 24, 2024, to July 22, 2025, are encouraged to contact The Gross Law Firm regarding possible lead plaintiff appointment. The firm alleges that during this time, Fiserv's defendants issued materially false and/or
Class action lawsuits
KinderCare, a national operator of early childhood education centers, is being investigated for potential securities fraud claims following the filing of a class action lawsuit. The lawsuit alleges that the Company failed to disclose widespread safety and compliance failures at its facilities, including instances of child abuse, neglect, and harm.
Class action lawsuits
Securities class action lawsuits are being pursued against Nutex Health Inc. (NASDAQ: NUTX) for investors who purchased securities between August 8, 2024, and August 14, 2025. The lawsuit was filed due to alleged false and/or misleading statements made by the company, leading to investors suffering damages. The Rosen Law
Class action lawsuits
Alto Neuroscience's initial public offering conducted on February 2, 2024, and its subsequent stock performance between February 2, 2024, and October 22, 2024, have raised questions about the company's business practices. A class action lawsuit has been filed on behalf of investors who purchased Alto securities
Class action lawsuits
Investors who purchased Snap Inc. securities between April 29, 2025, and August 5, 2025, have been notified of a class action lawsuit filed against the company and certain officers. The lawsuit alleges that Snap Inc. made false and misleading statements about its advertising revenue growth, concealing adverse facts and misrepresenting
Class action lawsuits
Neogen Corporation, a leading animal health company, has been hit with a class action lawsuit alleging securities fraud over a period of nearly two years. The lawsuit, filed on behalf of shareholders who suffered losses due to allegedly false and misleading statements made by the company's management, seeks
Class action lawsuits
Altimmune, Inc. shareholders who purchased shares between August 10, 2023, and June 25, 2025, are advised to contact The Gross Law Firm regarding possible lead plaintiff appointment after the company's announcement of disappointing topline results from the IMPACT Phase 2b MASH trial of Pemvidutide. The stock price plummeted
